Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Viatris recalled one lot of Xanax XR 3-mg extended-release tablets after failed dissolution testing, with the FDA classifying the action as Class II and reporting no adverse events to date.
Family Medicine/General Practice April 29th 2026
Dermatology Advisor
TNF-alpha inhibitor exposure was associated with adjusted hazard ratios of 1.99 for basal cell carcinoma, 1.69 for squamous cell carcinoma, and 1.54 for melanoma in a 56,209-patient retrospective cohort.
Dermatology April 28th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS